000046380 000__ 01095cam\a22003975i\4500
000046380 001__ 46380
000046380 003__ SzGeWIPO
000046380 005__ 20240708150240.0
000046380 006__ m\\\\eo\\d\\\\\\\\
000046380 007__ cr bn |||m|||a
000046380 008__ 220616s2021\\\\nyu\\\\\o\\\\\000\0\eng\d
000046380 035__ $$a(OCoLC)1335039051
000046380 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000046380 041__ $$aeng
000046380 24500 $$aThe EU Orphan Drug Regulation 20 years on: a quantitative and legal analysis.
000046380 264_1 $$a[New York, NY] :$$bThomson Reuters,$$c2022
000046380 300__ $$a1 online resource
000046380 336__ $$atext$$2rdacontent
000046380 337__ $$acomputer$$2rdamedia
000046380 338__ $$aonline resource$$bcr$$2rdacarrier
000046380 4901_ $$aEuropean Intellectual Property Review,$$x0142-0461 ;$$vVolume 44, Issue 7
000046380 542__ $$fhttps://1.next.westlaw.com/Copyright
000046380 588__ $$aCrossref
000046380 590__ $$aPublished online: 2022
000046380 650_4 $$aIntellectual property$$zEurope
000046380 650_0 $$aPharmaceutical policy.
000046380 650_0 $$aHealth.
000046380 7001_ $$aFoss-Solbrekk, Katarina,$$eauthor.
000046380 7001_ $$aAugustin, David,$$eauthor.
000046380 7731_ $$tEuropean Intellectual Property Review
000046380 7731_ $$wEIPR
000046380 830_0 $$aEuropean Intellectual Property Review,$$vE.I.P.R. 2022, 44(7), 395-404
000046380 85641 $$uhttps://www.westlaw.com/Document/I2F03C980EAAA11ECA0C0B8AF41D0B143/View/FullText.html?transitionType=Default&contextData=(sc.Default)&VR=3.0&RS=cblt1.0&sp=wlnintell-000$$yonline version
000046380 904__ $$aJournal article
000046380 980__ $$aEIPR